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The hypoglycemic activity of a crude acetone extract of the root bark of Euclea undulata var. myrtina was evaluated in a streptozotocin–
nicotinamide induced type 2 diabetes rat model after positive results were obtained by in vitro screening of glucose utilization by C2C12 myocytes,
3T3-L1 preadipocytes and Chang liver cells and alpha-glucosidase inhibition. Thirty male Wistar rats were used for the experiment. Type 2 diabetes
was induced by a single intraperitoneal injection of streptozotocin and administration of nicotinamide 15 min after. Animals exhibiting fasting glucose
levels of 140–200 mg/dl after 7 days were screened as type 2 diabetes. Extract was administered for 21 days orally at a concentration of 50 mg/kg and
100 mg/kg respectively. Glibenclamide (1 mg/kg) was used as positive control. On day 21, blood lipid proﬁles and body weight were determined by
using standard enzymatic colorimetric kits before the rats were sacriﬁced by cervical decapitation. The crude acetone extract of E. undulata root bark at
a concentration of 100 mg/kg body weight signiﬁcantly lowered fasting blood glucose levels as well as elevated cholesterol and triglyceride levels to
near normal without any weight gain. The results indicate that the crude acetone root bark extract of E. undulata exhibit antidiabetic activity in
type 2 induced diabetic rats. It conﬁrms the in vitro screening results as well as its use in the treatment of diabetes by traditional healers and herbalists in
southern Africa.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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Diabetes mellitus is an in-curable metabolic disease managed
and treated in first world countries by using conventional synthetic
drugs. In many third world and developing countries however,
diabetic patients make use of traditional medicinal herbs and
remedies as it is more easily accessible and affordable (Agarwal,
1985). Diabetes mellitus is characterized by hyperglycemia and
glucose intolerance associated with abnormalities in carbohydrate,
protein and fat metabolism due either to total or partial insulin
deficiency, or to the impaired effectiveness of insulin's action,⁎ Corresponding author. Tel.: +27 12 4204046; fax: +27 12 4206668.
E-mail address: miranda.deutschlander@up.ac.za (M.S. Deutschländer).
0254-6299/$ -see front matter © 2012 SAAB. Published by Elsevier B.V. All rights
doi:10.1016/j.sajb.2012.02.006or to a combination of both (O'Brain and Granner, 1991) The
number of individuals with type 2 diabetes in developing countries
has increased due to the adoption of a western diet and life style
and is a growing concern (Lehohla, 2006). Diabetes is associated
with an increase in ischemic heart disease, stroke, hypertensive
disease, renal failure, blindness and other debilitating diseases.
According to a survey done by Bradshaw et al. (2007), 5.5% of
the people in South Africa in the age group 30 years and older
are diabetic and the number increases with age. They attributed
14% of ischemic heart disease, 10% of stoke, 12% of hypertensive
disease and 12% of renal disease to diabetes. The World Health
Organization (WHO) estimated that in 1998 there were 135 mil-
lion people with diabetes, 171 million in 2000 and it has been pro-
jected to increase to 366 million in 2030 (Bradshaw et al., 2007).reserved.
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resulted in a renewed interest in the use of natural and traditional
remedies for treating diabetes (Vesudevan and Garber, 2005).
Euclea undulata Thunb. var. myrtina (Ebenaceae) (common
guarri), a dense, erect, dioecious shrub or small tree is being
used by traditional healers and herbalists in the Venda area in
the treatment of diabetes. An aqueous infusion is being made
with ground root bark and drank as a tea. It was selected for the
identification of bio-active principles after preliminary in vitro
screenings were done for hypoglycemic activity on an acetone
extract of the root bark. This selection was based on the facts
that the crude acetone extract of E. undulata root bark gave
positive results (hypoglycemic activity) in the in vitro assays
done on C2C12 myocytes, 3T3-L1 preadipocytes and in
Chang liver cells without displaying any toxicity and scored
a +3 according to the scoring system developed by Van de
Venter et al. (2008). The carbohydrate-hydrolyzing enzymes
alpha-amylase and alpha-glucosidase were also inhibited to
some extent (Deutschländer et al., 2009). The exact mechanism
of action still needs to be investigated. It is possible that it might
be two fold due to the presence of two isolated compounds from
the crude acetone extract namely the flavonoid epicatechin that
showed the potential to lower blood glucose levels in an in vitro
assay on C2C12 myocytes and the triterpene α-amyrin-3O-ß-
(5-hydroxy) ferulic acid that had the ability to inhibit alpha-
glucosidase (Deutschländer et al., 2011).
2. Materials and methods
2.1. Plant material
Plant material was collected at DeWagensdrift, Gauteng, South
Africa in August 2005. GPS coordinates S 25°22′11,15″ and E
28°22′52,0″. Voucher specimens (Deutschländer nr 95254)
have been deposited at the H.G.W.J. Schweickert Herbarium,
University of Pretoria and authenticated by Ms M. Nel.
2.1.1. Extraction of the plant material
Plant material was air dried and the root bark stripped from
the roots before it was ground. The ground root bark (215 g)
was soaked in 0.5 l acetone for three days while on a shaker.
After three days the extract was filtered and the residue was
extracted again with fresh acetone (3×). The plant extractsTable 1
Effect on fasting blood glucose level in streptozotocin–nicotinamide induced diabet
Group Fasting blood glucose level (mg/dl)
Initial 1st day 4th d
Normal control 71.00±1.32 71.67±1.54 70.
Diabetic control 160.83±6.51 ⁎ 162.5±6.45 ⁎ 167.
Diabetic+ test drug (50 mg/kg) 160.17±5.81 152.83±5.88 144.
Diabetic+ test drug (100 mg/kg) 164.83±5.61 147.83±7.29 128.
Diabetic+glibenclamide (1 mg/kg) 161.67±4.27 141.33±4.78 119.
Values are expressed as mean±S.E.M. (n=6).
⁎ pb0.01 when compared with normal control.
⁎⁎ pb0.05 when compared with diabetic control.
⁎⁎⁎ pb0.01 when compared with diabetic control.were combined and evaporated using a rotary evaporator to
yield 87 g (40%) total extract.
2.2. Animals
Thirty healthy male Wistar rats between 2 and 3 months old,
weighing 180–200 gwere used for the execution of this study. An-
imals were housed in standard polypropylene cages (4 per cage)
and maintained under standard laboratory conditions (12 h light-
dark cycle; temperature 20±2 °C; relative humidity 50±15%).
They were fed a standard rat pellet diet (Hindustan Liver Ltd.
Mumbai, India) and had access to water ad libitum. The principles
of Laboratory Animal care (Public Health Services, 1986) were
followed throughout the duration of the experiment.
2.3. Chemicals
Streptozotocin used for the induction of diabetes in the Wistar
rats was obtained from SISCO Research Laboratory PVT. Ltd.
India and nicotinamide was purchased from Qualigens Fine
Chemicals, Division of Glaxo,Mumbai, India. The other reagents
used for the execution of the experiment were of analytical grade.
Glibenclamide (Daonil™, Hoechst, India) used as positive con-
trol, was purchased from a local medical store, Jadavpur, India.
2.4. Rat antihyperglycemic assays
2.4.1. Induction of diabetes
Hyperglycemia was induced in overnight fasted adult male
Wistar rats weighing between 180 and 200 g by a single intraper-
itoneal injection of 65 mg/kg streptozotocin in a citrate buffer
(pH 4.5) to a volume of 1 mg/kg body weight (Siddque et al.,
1987; Maiti et al., 2009) and the administration of nicotinamide
(110 mg/kg i.p) 15 min later (Masiello et al., 1998). Animals
exhibiting fasting glucose levels of 140–200 mg/dl after 7 days
were screened as type 2 diabetic rats and used for the experiment
(Dewanjee et al., 2009).
2.4.2. Experimental design
Animals were divided into five groups of six rats each. The
vehicle and extract were administered orally for 21 days.
Group 1: Normal control ratsic rats.
ay 7th day 14th day 21st day
83±1.54 71.83±1.20 71.67±1.28 71.50±1.50
83±6.70 ⁎ 169.00±5.13 ⁎ 171.33±5.13 ⁎ 171.83±4.28 ⁎
67±5.39 ⁎⁎ 140.33±6.72 ⁎⁎⁎ 133.33±5.74 ⁎⁎⁎ 128.00±5.73 ⁎⁎⁎
67±7.83 ⁎⁎⁎ 124.67±6.83 ⁎⁎⁎ 117.67±5.96 ⁎⁎⁎ 114.33±6.32 ⁎⁎⁎
33±4.06 ⁎⁎⁎ 116.33±3.91 ⁎⁎⁎ 108.67±4.28 ⁎⁎⁎ 107.50±5.10 ⁎⁎⁎
Table 3




Normal control 165.00±4.08 169.17±4.36
Diabetic control 152.50±6.55 136.50±5.18
Diabetic+ test drug (50 mg/kg) 159.17±3.75 149.17±5.83
Diabetic+ test drug (100 mg/kg) 157.50±8.92 152.67±7.46
Diabetic+glibenclamide (1 mg/kg) 157.00±4.95 155.83±4.55
Values are expressed as mean±S.E.M. (n=6).
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Group 3: Diabetic rats administered test drug at a dose of
50 mg/kg
Group 4: Diabetic rats administered test drug at a dose of
100 mg/kg
Group 5: Diabetic rats administered glibenclamide at a dose
of 1 mg/kg
Blood samples were drawn by retro-orbital puncture and fasting
glucose levels were estimated on days 0, 1, 4, 7, 14 and 21 by using
a single touch glucometer (Ascensia Entrust, Bayer Health Care,
USA). Blood lipid profiles and body weight were determined on
day 21 by using standard enzymatic colorimetric kits (Span
Diagnostics Ltd., Surat, India) after which the rats were sacrificed
by intervention by cervical decapitation.
2.5. Statistical analysis
Data were statistically evaluated by using one way ANOVA,
expressed as mean±S.E.M. The results were further analyzed by
applying Dun-nett's t-test using GraphPad InStat version 3.05,
Graph pad software, U.S.A. A p-valueb0.05 was considered to
be significant (Maiti et al., 2009).
3. Results and discussion
The crude acetone extract of E. undulata var. myrtina at a
concentration 100 mg/kg body weight significantly lowered
fasting blood glucose levels of type 2 diabetic rats when com-
pared with the diabetic control rats (Table 1). Treatment with
the crude acetone extract at a concentration of 100 mg/kg
body weight of E. undulata significantly lowered the elevated
cholesterol and triglyceride levels to near normal status when
compared with the diabetic control group (Table 2). The effect
of the crude acetone extract on the final body weight of strepto-
zotocin–nicotinamide induced diabetic rats is given in Table 3.
The results indicated that there were no significant weight gains
or losses after 21 days in the diabetic rats treated with the
E. undulata crude acetone extract at a concentration of
100 mg/kg body weight. The results indicate that the crude ac-
etone root bark extract of E. undulata exhibits antidiabeticTable 2
Effect on blood lipid profile (after sacrifice on day 21) in streptozotocin–
nicotinamide induced diabetic rats.
Group Blood lipid level (mg/dl)
Cholesterol Triglycerides
Normal control 54.24±1.88 52.17±1.02
Diabetic control 92.13±3.21⁎ 102.76±2.12 ⁎
Diabetic+ test drug (50 mg/kg) 78.67±2.04 ⁎⁎ 87.67±3.13 ⁎⁎
Diabetic+ test drug (100 mg/kg) 71.33±1.22 ⁎⁎ 76.50±2.54 ⁎⁎
Diabetic+glibenclamide (1 mg/kg) 57.50±2.39 ⁎⁎ 68.65±1.92 ⁎⁎
Values are expressed as mean±S.E.M. (n=6).
⁎ pb0.01 when compared with normal control.
⁎⁎ pb0.01 when compared with diabetic control.activity in type 2 induced diabetic rats and confirms the in
vitro assay results on C2C12 myocytes, 3T3-L1 preadipocytes
and Chang liver cells. The crude acetone extract (at 50 μg/ml)
lowered blood glucose levels in C2C12 myocytes 62.2%, 3T3-
L1 preadipocytes 26.0% and in Chang liver cells 19.7%
(Deutschländer et al., 2009). Phytochemical examination coupled
with bioassay-guided fractionation of the crude acetone extract
led to the isolation of four compounds of which epicatechin
has the ability to lower blood glucose levels 82.8% in C2C12
myocytes and α-amyrin-3O-ß-(5-hydroxy) ferulic acid has the
ability to inhibit alpha-glucosidase 68% (Deutschländer et al.,
2011).4. Conclusions
Phytochemical studies conducted on Euclea species by
Costa et al. (1978) demonstrated the presence of triterpenoids
in the stems and leaves. Two naphthoquinones, diospyrin and
7 methyl-juglone, were isolated from the root, stem and fruit
of E. undulata var. myrtina by Van der Vyver and Gerritsma
(1973, 1974). Chemical analysis indicated the presence of
3.26% tannins in bark, saponins and reducing sugars in leafs
and stems, but no alkaloids, naphthoquinones or cardiac glyco-
sides (South African National Biodiversity Institute, 2005).
Deutschländer et al. (2011) isolated a new α-amyrine-3O-ß-5-
hydroxy) ferulic acid, the triterpenes betulin and lupeol and
the flavonoid epicatechin from the crude acetone root bark
extract from E. undulata.
The in vivo results obtained in streptozotocin–nicotinamide
induced type 2 diabetic rats indicated that the crude acetone
extract of E. undulata at a concentration of 100 mg/kg body
weight has the ability to lower blood glucose levels as well
as normalize elevated cholesterol and triglyceride levels when
compared to that of the diabetic control group. The in vivo results
obtained with the crude acetone extract of E. undulata corrobo-
rate the in vitro results that the crude acetone root bark extract
of E. undulata has the ability to lower blood glucose levels
(Deutschländer et al., 2009). These findings confirm the eth-
nomedicinal use of E. undulata by traditional healers for the
treatment of diabetes. Histological analysis should however
still be done on the vital organs such as the pancreas and
liver to determine if the crude acetone extract are responsible
for any histopathological changes in these organs.
12 M.S. Deutschländer et al. / South African Journal of Botany 80 (2012) 9–12References
Agarwal, O.P., 1985. Prevention of atheromatous heart disease. Angiology 36,
485–492.
Bradshaw, D., Norman, R., Pieterse, D., Levitt, N.S., The South African
Comparative Risk Assessment Collaborating Group, 2007. Estimating the
burden of disease attributable to diabetes in South Africa in 2000. South
African Medical Journal 97, 700–706.
Costa, M.A.C., Paul, M.I., Alves, A.A.C., Van der Vyver, L.M., 1978. Aliphatic
and triterpenoid compounds of Ebenaceae species. Revista Portuguesa de
Farmácia 28, 171–174.
Deutschländer, M.S., Van de Venter, M., Roux, S., Louw, J., Lall, N., 2009.
Hypoglycaemic activity of four plant extracts traditionally used in South
Africa for diabetes. Journal of Ethnopharmacology 124, 619–624.
Deutschländer, M.S., Lall, N., Van de Venter, M., Hussein, A.A., 2011. Hypo-
glycaemic evaluation of a new triterpene and other compounds isolated
from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. Journal
of Ethnopharmacology 16, 1091–1095.
Dewanjee, S., Das, A.K., Sahu, R., Gangopdhyay, M., 2009. Antidiabetic activity
of Diospyros peregrine fruit: effect on hyperglycemia, hyperlipidemia and
augmented oxidative stress in experimental type 2 diabetes. Food and Chemi-
cal Toxicology 47, 2679–2685.
Lehohla, P., 2006. Knowing Causes of Death is Crucial for Planning. Business
Report. 14 Sept 2006. Statistics South Africa. http://www.statssa.gov.za/
news_archive/14September2006_1.asp. accessed 2009/06/08.
Maiti, A., Dewanjee, S., Kundu, M., Subhash, C.M., 2009. Evaluation of anti-
diabetic activity of the seeds of Swietenia macrophylla in diabetic rats.
Pharmaceutical Biology 47, 132–136.Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys,
D., Novelli, M., Ribes, G., 1998. Experimental NIDDM: development of
a new model in adult rats administered streptozotocin and nicotinamide.
Diabetes 47, 224–229.
O'Brain, R., Granner, D., 1991. Regulation of gene expression by insulin.
Biochemical Journal 278, 609–619.
Public Health Service, 1986. Public Health Service Policy on Humane Care and
Use of Laboratory Animals. Washington D.C., US, Department of Health
and Human Services. Available from the Office for Protection from Research
Risks, Building 31, Room 4B09, Nlll, Bethesda, MD 20892.
Siddque, M., Sun, Y., Lin, J.C., Chien, Y.W., 1987. Facilitated transdermal
transport of insulin. Journal of Pharmacological Sciences 76, 341–345.
South African National Biodiversity Institute, South African Medical Research
Council, University of the Western Cape, 2005. E. undulata Herba. Available
at: http://www.plantzafrica.com/medmonographs/eucleaundulata.pdf (2005/
11/28).
Van de Venter, M., Roux, S., Bungu, L.C., Louw, J., Crouch, N.C., Grace,
O.M., Maharaj, V., Pillay, P., Sewnarian, P., Bhagwandin, N., Folb, P.,
2008. Antidiabetic screening and scoring of 11 plants traditionally used in
South Africa. Journal of Ethnopharmacology 119, 81–86.
Van der Vyver, L.M., Gerritsma, K.W., 1973. Naphtoquinones of Euclea and
Diospyros species. Phytochemistry 12, 230–231.
Van der Vyver, L.M., Gerritsma, K.W., 1974. Napthoquinones of Euclea and
Diospyros species. Phytochemistry 13, 2322–2323.
Vesudevan, A.R., Garber, A.J., 2005. Insulin resistance syndrome. A review.
Minerva Indocrinology 30, 101–119.Edited by AK Jäger
